FLT1 and early-onset autosomal dominant Alzheimer disease: Longitudinal biomarker analyses indicate that Flt-1 and IL-15 are elevated within CSF at preclinical, prodromal, and dementia stages of Alzheimer’s disease, and are associated with cortical thinning and subsequent cognitive decline36.